Revenue | ₹29.14Cr |
Net Profits | ₹4.13Cr |
Net Profit Margins | 14.17% |
Par Drugs & Chemicals Ltd’s revenue fell -18.31% since last year same period to ₹29.14Cr in the Q2 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 4.52% jump in its revenue since last 3-months.
Par Drugs & Chemicals Ltd’s net profit fell -51.98% since last year same period to ₹4.13Cr in the Q2 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 24.02% jump in its net profits since last 3-months.
Par Drugs & Chemicals Ltd’s net profit margin fell -41.22% since last year same period to 14.17% in the Q2 2025-2026. On a quarterly growth basis, Par Drugs & Chemicals Ltd has generated 18.66% jumped in its net profit margins since last 3-months.
The revenue for Par Drugs & Chemicals Ltd in the Q2 results 2025 was ₹29.14Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q2 results 2025 was ₹4.13Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q2 results 2025 was 14.17%.
The revenue for Par Drugs & Chemicals Ltd in the Q2 results 2024 was ₹35.67Cr.
The net profit for Par Drugs & Chemicals Ltd in the Q2 results 2024 was ₹8.60Cr.
The net profit margin for Par Drugs & Chemicals Ltd in the Q2 results 2024 was 24.11%.